<DOC>
	<DOCNO>NCT01895933</DOCNO>
	<brief_summary>This clinical trial intend evaluate impact , efficacy , safety Chitosan formulate adhesion inhibitor , SurgiShield use process wound heal endoscopic sinus surgery .</brief_summary>
	<brief_title>Efficacy Safety Investigational Device , SurgiShield Anti-Adhesion Barrier Gel</brief_title>
	<detailed_description />
	<criteria>old 21 year age side sinusitis undergo endoscopic sinus surgery volunteer inform consent signature suppress immunity patient systemic grave condition pregnant cancer severe disease patient asthma patient AIDS cystic fibrosis ciliary immobility syndrome neutropenia neutrophil immunoglobulin deficiency wound heal immune disease severe liver disease severe kidney disease lymph blood clot disorder patient treat coagulant patient take oral parenteral glucose diabetes thrombocytopenia infectious disease currently lactate severe septal deviation case severe difference sinusitis state side nose : 3 score difference LundMackey CT scan scoring system PNS ( ParaNasalSinus ) shellfish allergy food allergy endoscopic sinus surgery past patient large sinus polyps patient receive treatment extrasinus complication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Investigational device ( chitosan gel )</keyword>
	<keyword>Wound heal</keyword>
	<keyword>Endoscopic sinus surgery</keyword>
	<keyword>SurgiShield</keyword>
</DOC>